Results of Treatment With Hyper-CVAD, a Dose-Intensive Regimen, in Adult Acute Lymphocytic Leukemia
Top Cited Papers
- 1 February 2000
- journal article
- clinical trial
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 18 (3), 547
- https://doi.org/10.1200/jco.2000.18.3.547
Abstract
PURPOSE: To evaluate the efficacy and toxicity of Hyper-CVAD (fractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone), a dose-intensive regimen, in adult acute lymphocytic leuke...Keywords
This publication has 72 references indexed in Scilit:
- Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XILeukemia, 1998
- Proportional hazards tests and diagnostics based on weighted residualsBiometrika, 1994
- High expression of bcl-2 is the rule in acute lymphoblastic leukemia, except in Burkitt subtype at presentation, and is not correlated with the prognosisAnnals of Hematology, 1994
- Granulocyte colony-stimulating factor supportive treatment following intensive chemotherapy in acute lymphocytic leukemia in first remissionCancer, 1993
- Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL)Annals of Hematology, 1993
- Martingale-based residuals for survival modelsBiometrika, 1990
- Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 casesBritish Journal of Haematology, 1989
- Four-Agent Induction and Intensive Asparaginase Therapy for Treatment of Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1986
- Combination chemotherapy for acute lymphocytic leukemia in adults: Results of a retrospective study in 82 patientsAmerican Journal of Hematology, 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958